Loading Events

« All Events

Virtual Event
  • This event has passed.

PF Warriors: Review of the FIBRONEER-ILD Study: Nerandomilast (JASCAYD) in PPF – January 10, 2026

January 10 @ 10:00 am - 11:30 am CST
Virtual Event
Free
January 2026 PF Warrior Educational Meeting with Dr. Toby Maher of Keck Medicine, USC

On Friday, December 19th, the U.S. Food and Drug Administration (FDA) approved JASCAYD (nerandomilast) for progressive pulmonary fibrosis (PPF).

We know many patients and caregivers have questions. To help address them, PF Warriors invites you to join an upcoming educational meeting focused on understanding this research.

Dr. Toby Maher, MD, MSc, PHD, Director of the Interstitial Lung Disease Center at Keck Medicine of USC, will review findings from the FIBRONEER-ILD study and discuss the data, as well as how this information may be used to support conversations with your medical team.

What You’ll Learn:
1. Understand the purpose and design of the FIBRONEER-ILD study, including who participated and what outcomes were measured.
2. Review the key study results, including what the data show and what questions may remain.
3. How to use the information from the study to discuss treatment options with your healthcare team, recognizing that treatment decisions are individualized and based on personal health needs.

Whether you’re newly diagnosed, have been living with PF for years, or are caring for someone you love, this session will offer clear, meaningful insights to help you better understand the study findings and feel more prepared for conversations with your healthcare team.

Following the presentation, Dr. Maher will answer your questions in a live Q&A session.

Join PF Warriors for our monthly educational meeting which happens every second Saturday of the month. Hear from experts, ask questions, and gain insights into managing and living with pulmonary fibrosis (PF).

Details

Organizer